Advertisement
Business
Ardelyx President and CEO Sells 41,000 Shares for $243,000
April 3, 2026
The Motley Fool
Scroll
This biotech innovator in gastrointestinal and kidney therapies reported a notable insider sale amid routine portfolio adjustments.
The Motley Fool
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
Advertisement